Paths of Ink is an international invitational exhibition featuring eight artists from Japan and Korea who pursue innovative new movements in calligraphy, amplifying age-old traditions into a ...
Growing up near Beijing's Xiangshan Mountain, Zhang Zhaohui has long nurtured a deep connection to trees and the natural ...
He wandered through the open-air markets, testing his language skills and admiring the wares – especially items featuring ...
All these deals have one thing in common — all the companies have in-licensed their respective PD-1/VEGF drugs from Chinese biotechs. Summit acquired the exclusive license for ivonescimab from ...
All these deals have one thing in common — all the companies have in-licensed their respective PD-1/VEGF drugs from Chinese biotechs. Summit acquired the exclusive license for ivonescimab from Akeso ...
UK-based Hong Kong artist Chris Huen Sin-kan was recently in Vancouver in Canada to attend the opening of his solo show at the Centre of International Contemporary Art (CICA), presenting paintings ...
Lim’s art chronicles this remarkable journey. His early Chinese ink paintings capture the rustic charm of old Singapore – the kampungs, the Singapore River and bustling street markets – before the ...
A unique exhibition featuring 15 bird-themed paintings from the Song Dynasty (960-1279), showcasing the pinnacle of traditional Chinese ink-wash art, is on display at Zhejiang Museum as it celebrates ...
An exhibition reviewing 40 years of China's contemporary ink paintings is underway ... Modernization of Art Deco," an exhibition marking 60 years of Chinese-French diplomatic ties, opened Nov ...
GSK Plc acquired an experimental drug from Chinese biotech firm Chimagen Biosciences for as much as $850 million, adding to the British drugmaker’s pipeline of potential treatments for lupus.
KUALA LUMPUR: Chinese waste treatment conglomerate Shanghai SUS Environment Co Ltd is looking to inject RM15bil of foreign direct investment (FDI) into the economy via a collaboration to establish ...